Marico sales up 26% YoY: Q3 FY26 and FY25 snapshot

Key update at a glance

Marico reported strong top-line growth in the quarters ended September 2025 and December 2025, with both standalone and consolidated net sales rising at a high-teens to 30% pace year-on-year. The latest reported numbers show standalone December 2025 net sales of ₹2,461 crore, up 25.24% YoY, and consolidated December 2025 net sales of ₹3,537 crore, up 26.59% YoY. For the quarter ended September 2025, consolidated net sales were reported at ₹3,482 crore, up 30.71% YoY, while standalone net sales were ₹2,426 crore, up 30.43% YoY.

The updates add to a broader FY25 narrative where Marico reported 20% YoY revenue growth in Q4FY25 and crossed ₹10,000 crore in annual revenue for FY25. Across the period, the company has also flagged cost inflation, especially in copra and vegetable oils, as a key factor affecting margins.

Standalone and consolidated sales: what changed

The September and December 2025 net sales figures indicate that Marico’s growth remained broad-based, with consolidated sales consistently ahead of standalone, reflecting contributions from the international business and subsidiaries. The company’s consolidated December 2025 net sales (₹3,537 crore) were higher than the September 2025 quarter (₹3,482 crore), while maintaining a strong YoY growth rate.

Standalone net sales show a similar pattern, with September 2025 at ₹2,426 crore and December 2025 at ₹2,461 crore. Both quarters recorded YoY growth above 25%, pointing to a continuation of strong demand and/or pricing actions in the India-focused reported entity.

Q1FY26 results: revenue up 23%, profit up 9%

Marico’s Q1FY26 performance provides additional context on the drivers behind the sales trajectory. The company reported revenue from operations of ₹3,259 crore in Q1FY26, compared with ₹2,643 crore in Q1FY25, a 23% YoY increase. Net profit rose 9% YoY to ₹504 crore from ₹464 crore.

Operating indicators, as disclosed for the quarter, showed EBITDA at ₹655 crore versus ₹626 crore (up 5% YoY) and PBT at ₹656 crore versus ₹605 crore (up 8% YoY). The company also reported India volume growth of 9%, international constant currency growth of 19%, and international business revenues up 12% in INR terms due to currency headwinds.

Q4FY25: revenue growth despite margin pressure

In Q4FY25, Marico reported consolidated revenue from operations of ₹2,730 crore, up 20% YoY, and consolidated PAT of ₹343 crore, up 8% YoY. EBITDA rose 4% to ₹458 crore, while the EBITDA margin declined to 16.8%, a contraction of about 260 basis points, alongside a gross margin contraction of about 300 basis points.

The company attributed margin pressure primarily to higher copra and vegetable oil prices, while noting that pricing interventions in key portfolios partly offset the impact. Advertising and promotion (A&P) expenditure in Q4 rose 35% YoY, aligned with the stated intent to strengthen brands and support diversification.

FY25 milestones: revenue crosses ₹10,000 crore

For FY25, Marico reported total revenue from operations of ₹10,831 crore, marking a 12% YoY increase and taking annual revenue beyond the ₹10,000 crore level. The India segment recorded 5% volume growth for the year, while the international segment delivered 14% constant currency growth.

The company also noted that its Foods and Premium Personal Care portfolio reached an annualised revenue run rate of ₹2,000 crore. In FY25, copra prices were reported to be up 48% YoY, a key input cost headwind for the coconut oil portfolio.

Dividend and investor actions

Following the Q4FY25 results, Marico declared a final dividend of ₹7 per equity share for FY25, taking the total dividend for FY25 to ₹10.50 per share. The results commentary also indicated clean, unmodified audit opinions for standalone and consolidated accounts, and no exceptional items were reported in the referenced summary.

Market reaction and what investors tracked

Marico’s shares were reported to have surged about 5% after the Q4FY25 profit and revenue update, with the move described as its sharpest single-day gain since June of the prior year in one report. The stock was also referenced as trading up 4.20% at ₹727.05 and hitting a high of ₹735.25 in that market snapshot.

Alongside the headline growth, investor focus remained on the balance between pricing-led gains, volume trajectory in India, and the extent and duration of commodity inflation-led margin pressure.

Summary table: reported financial and operating data

Why the numbers matter

The September and December 2025 net sales prints suggest Marico sustained strong growth after an FY25 where revenue crossed ₹10,000 crore, even as profitability faced pressure from commodity costs. The Q1FY26 snapshot shows that revenue growth continued at 23% YoY with a 9% increase in net profit, indicating that earnings held up despite input cost challenges highlighted in Q4FY25.

For investors, the key linkage across these periods is the interaction of pricing actions, India volume growth, and international growth in constant currency terms, versus the margin impact from copra and vegetable oil inflation and higher A&P spending. Management commentary in the provided material also indicated a stance of cautious optimism, with a stated target of double-digit revenue growth amid ongoing commodity-related risks.

Conclusion

Marico’s reported standalone and consolidated net sales for the September and December 2025 quarters extend a run of strong top-line growth seen through FY25 and into Q1FY26. The next set of results will be watched for how margin trends evolve given the company’s stated exposure to copra and vegetable oil inflation and its continued investment in brand building.